Tomer Kariv

Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

Ovalum Ltd. was established in March 2005 by Noam Shamay and Eitan Finkelstein. The company is located in Rabin Science Park Rehovot, Israel. Ovalum Ltd. focuses on the development and implementation of effective and safe solutions for chronic and acute total occlusions in the coronary and peripheral arteries. Based on proprietary shape memory alloy techniques and unique knowledge of laser processes, Ovalum Ltd. develops systems that will revolutionize the minimally-invasive cardiology and interventional radiology fields. The innovative minimally-invasive solution, the CiTop™ guidewire system, was created for the treatment of arterial conditions that today require bypass surgery or amputation of the lower limb.

Sullivan & Cromwell LLP provides legal services. It specializes in the areas of corporate law, securities, corporate, litigation, mergers, real estate, pro bono, investment management and taxation. Their clients include industrial, commercial, financial, private funds, governmental, educational, charitable and cultural enterprises and entities. The company was founded by Algernon Sydney Sullivan and William Nelson Cromwell in 1879 and is headquartered in New York City, NY.

Aposense Ltd. engages in the provision of proprietary conjugates. It offers platform technology which comprises the rational design of small molecular moieties with the increased affinity to the cell membranes imparting the conjugates compound with improved drug properties such as extended life span oral bioavailabity and selective at target site. The company was founded by Ilan Ziv and Jacob Gottenstein on October 9, 1996 and is headquartered in Petach-Tikva, Israel.

Pontifax Management Co. Ltd. (Pontifax) is a venture capital firm founded in 2004 by Eliyahu Hurvitz. The firm is headquartered in Herzliya Pituach, Israel.

CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel.

I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel.

ReLeaf Medical Ltd. develops medical devices to treat calcification related diseases. The company was founded by Moshe Y. Flugelman and Yael Nir in September 2006 and is headquartered in Kiryat Shmona, Israel.

Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel.

Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA.

Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel.

Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel.

Adicet Bio Israel Ltd. develops therapeutic molecules for cancer, viral, and autoimmune diseases. The firm’s technologies include AIT develops a therapeutic antibodies T-Cell Receptor Like. Its TCRL antibodies have diagnostic applications in pathology, vaccine design, validation, and monitoring. The company was founded by Mira Peled-Kamar and Yoram Reiter in 2006 and is headquartered in Haifa, Israel.

T.D.L International Directions Ltd. engages in the provision of international business development services. The company was founded by Todd Dollinger and Steve Rhodes in 1993 and is headquartered in Misgav Regional Council, Israel.

V-Wave Ltd. engages in the development of implantable medical device for treating chronic heart failure. It offers V-Wave Shunt, which is a biocompatible inter-atrial unidirectional implant. The company was founded by Gad Keren and Yaacov Nitzan in 2009 and is headquartered in Caesarea, Israel.

HeadSense Medical Ltd. develops disruptive products that allow physicians and patients to diagnose and monitor clinical parameters. The firm manufactures non invasive multi parameter brain monitor. Its products used in neurosurgery, neurology, emergency medicine and critical care. The company was founded by Guy Weinberg and Surik Papyan in 2011 and is headquartered in Netanya, Israel.

Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA.

CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel.

Aliment Capital LLC (Aliment Capital) is a venture capital subsidiary of Pontifax Management Co. Ltd. founded in 2014 by Philip Robert Erlanger and Ben Belldegrun. The firm is headquartered in California, United States.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Pi Therapeutics Ltd. develops a proprietary cancer drug. The company was founded by Ori Kalid in March 2015 and is headquartered in Ness Ziona, Israel.

Part of Check-Cap Ltd., Check-Cap Ltd. (Delaware) develops clinical-stage medical diagnostics devices.

Part of Pontifax Management Co. Ltd., Pontifax (Israel) IV LP is an investment services provider. The private company is based in Hertsliya, Israel and was founded in 2015.